Status:

COMPLETED

Comprehensive Care in Type 1 Diabetes and Associated Outcomes

Lead Sponsor:

Universidad de Antioquia

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

15+ years

Phase:

NA

Brief Summary

Quasi-experimental, retrospective, before and after study, with a control group, to evaluate the effect of an intervention based on disease management, on metabolic control and hospitalizations, in a ...

Detailed Description

Evaluate the effect of an intervention based on the management of the disease, on metabolic control and the number of hospitalizations related to diabetes, in a group of patients with Type 1 Diabetes ...

Eligibility Criteria

Inclusion

  • Patients diagnosed with type 1 diabetes.
  • Patients affiliated to the Entity Administrator of Health Benefits Plans (EPS Sura)
  • Patients with age greater than or equal to 15 years, who had been referred to the institution at the discretion of the treating physician, for poor metabolic control and had to enter a hemoglobin glycated (HbA1C) ≥ 7.0%.

Exclusion

  • Patients who at the time of recruitment were treated with continuous insulin infusion device (insulin pump) and patients with gestational diabetes were excluded.

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 28 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03835195

Start Date

June 1 2018

End Date

March 28 2019

Last Update

June 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clínica Integral de Diabetes

Medellín, Antioquia, Colombia